Designer Drug Confusion: A Focus on MDMA

MDMA, also called Ecstasy or Adam, is a designer drug with both stimulant and psychedelic properties that creates a unique effect sought by recreational users. Despite its recent illegality and growing evidence of neurotoxicity, interest in MDMA is expected to persist. The article examines the drug's recreational appeal and therapeutic potential, concluding that much more research is needed to understand both its possible benefits and risks.

Study at a glance

Abstract

This article discusses the competing definitions and issues surrounding the various desgner drugs, but is primarily devoted t o an examination of MDMA, an increasingly popular substance often labeled as a designer drug. Also known as “Ecstasy” or “Adam,” MDMA possesses both stimulant and psychedelic properties which combine to produce a unique effect desired by many users. The authors offer a rationale for why interest in MDMA will continue to grow despite the drug's recent illegality and the increasing evidence of neurotoxicity. MDMA's recreational attraction and therapeutic potential are discussed. Much more research is necessary to address both the potential benefits and risks of this controversial substance.